Feng Yue, Ph.D.

The genetic makeup and structure of glioblastoma tumors can shift dramatically across different regions of a single tumor, according to a Northwestern Medicine study published in Science Advances.

Glioblastoma, the most common primary malignant brain tumor, currently has a five-year survival rate of only 6.9 percent, according to the National Brain Tumor Society. Despite evolving therapy strategies, glioblastoma is extremely treatment-resistant, with an average length of survival of only eight months.

Part of the reason glioblastoma is so difficult to treat is due to the tumors’ ability to rapidly mutate its DNA, according to Feng Yue, PhD, the Duane and Susan Burnham Professor of Molecular Medicine and senior author of the study… Continue reading.

WASHINGTON, D.C. – The American Institute for Medical and Biological Engineering (AIMBE) has announced the induction of Feng Yue, Ph.D., Professor and Director of Biochemistry and Molecular Genetics at Northwestern University to its College of Fellows.

Election to the AIMBE College of Fellows is among the highest professional distinctions accorded to medical and biological engineers, comprised of the top two percent of engineers in these fields. College membership honors those who have made outstanding contributions to “engineering and medicine research, practice, or education” and to “the pioneering of new and developing fields of technology, making major advancements in traditional fields of medical and biological engineering or developing/implementing innovative approaches to bioengineering education.”

Professor Yue was nominated, reviewed, and elected by peers and members of the College of Fellows “for the development of algorithms and visualization tools in genome annotation and regulatory network in human disease and evolution…. Continue reading.